Search hospitals > Tennessee > Knoxville
Alliance for Multispecialty Research, LLC
Claim this profileKnoxville, Tennessee 37920
Global Leader in Obesity
Global Leader in Type 2 Diabetes
Conducts research for Childhood Obesity
Conducts research for Diabetes Mellitus
Conducts research for Coronavirus
71 reported clinical trials
6 medical researchers
Summary
Alliance for Multispecialty Research, LLC is a medical facility located in Knoxville, Tennessee. This center is recognized for care of Obesity, Type 2 Diabetes, Childhood Obesity, Diabetes Mellitus, Coronavirus and other specialties. Alliance for Multispecialty Research, LLC is involved with conducting 71 clinical trials across 88 conditions. There are 6 research doctors associated with this hospital, such as William Smith, Lisa Connery, Michael A Rausch, and Harry E Studdard, MD.Top PIs
William SmithAlliance for Multispecialty Research, LLC1 year of reported clinical research
Studies Tobacco Use
Studies Smoking
31 reported clinical trials
52 drugs studied
Lisa ConneryAlliance for Multispecialty Research, LLC2 years of reported clinical research
Expert in Type 2 Diabetes
Expert in Diabetes Mellitus
22 reported clinical trials
18 drugs studied
Michael A RauschGSK Investigational Site4 years of reported clinical research
Studies Respiratory Syncytial Virus Infection
Studies Respiratory Syncytial Virus
11 reported clinical trials
14 drugs studied
Harry E Studdard, MDAlliance for Multispecialty Research, LLC1 year of reported clinical research
Studies Chikungunya
Studies Cardiovascular Disease
6 reported clinical trials
5 drugs studied
Clinical Trials running at Alliance for Multispecialty Research, LLC
Obesity
Cardiovascular Disease
Type 2 Diabetes
Vestibular Migraine
Diabetes Mellitus
Healthy Subjects
Psoriasis
Childhood Obesity
Migraine
High Cholesterol
Tirzepatide
for Psoriasis and Obesity
The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.
Recruiting3 awards Phase 4
Tirzepatide
for Type 1 Diabetes and Obesity
The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 weeks.
Recruiting1 award Phase 31 criteria
Tirzepatide
for Adolescent Obesity
The goal of the study is to assess how tirzepatide impacts bodyweight and cardiovascular risk factors when used in conjunction with healthy nutrition and physical activity in adolescents with obesity and multiple weight related comorbidities. The study will last approximately 76 weeks and may include up to 23 visits.
Recruiting1 award Phase 31 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Alliance for Multispecialty Research, LLC?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.